These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
10. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201 [TBL] [Abstract][Full Text] [Related]
15. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition. Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761 [TBL] [Abstract][Full Text] [Related]
16. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations. Mosquera-Yuqui F; Lopez-Guerra N; Moncayo-Palacio EA J Biomol Struct Dyn; 2022 Mar; 40(5):2010-2023. PubMed ID: 33084512 [TBL] [Abstract][Full Text] [Related]
17. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods. Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552 [TBL] [Abstract][Full Text] [Related]